Alpinia oxyphylla Miq. (Zingiberaceae) is widely cultivated and distributed in southern China. The fruits of this plant have been used as a traditional medicine in Korea and other oriental countries for the treatment of gastrointestinal disorders, urosis, diuresis, ulceration, and dementia. The plants in the genus of Alpinia are reported to be rich of diarylheptanoids, sesquiterpenoids, and flavonoids.
1 Previous pharmacological investigations have indicated that the fruits of A. oxyphylla possess various activities, including antioxidative, 2, 3 anti-inflammatory, 4 anti-angiogenic, 5 anti-ulcer, 6 and neuroprotective activities. [7] [8] [9] Recently, diarylheptanoids and sesquiterpenes have been isolated from this plant, and some of which showed the inhibitory effects on nitric oxide production. [10] [11] [12] [13] As part of our continuing search for inhibitors of nitric oxide (NO) production from medicinal plants, we investigated the active constituents of the fruits of A. oxyphylla. As a result, a new noreudesmane-type sesquiterpenoid, 4-methoxy-oxyphyllenone A (1), along with 15 known compounds was isolated and identified. The present paper describes the structure determination of the new compound 1 and the inhibitory effects of the isolated compounds on NO production.
The dried fruits of A. oxyphylla were extracted with methanol and fractionated successively with n-hexane, CH 2 Cl 2 , and water. The CH 2 Cl 2 -soluble fraction was subjected to various column chromatography and led to the isolation of the new noreudesmane-type sesquiterpenoid and 15 known compounds ( Figure 1) .
Compound 1 was isolated as a yellow gum. The HR-ESI-MS of compound 1 exhibited a protonated molecular ion peak at m/z 225.1485 [M+H] + (calcd. 225.1491) and established the molecular formula of C 13 H 20 O 3 , implying four degrees of unsaturation. The IR spectrum showed absorptions at 3271 and 1647 cm −1 , which indicated the presence of a hydroxyl and α,β-unsaturated ketone. The 1 H NMR spectrum of compound 1 displayed the presence of two tertiary methyls at δ H 1.37 (s, CH 3 -15) and 1.41 (s, CH 3 -14) , an oxygenated methine at δ H 3.70 (dd, J = 3.0, 3.0 Hz, H-3), a methoxyl group at δ H 3.06 (s, OCH 3 -4), and an olefinic proton at δ H 5.99 (s, H-6). The
13
C NMR and HMQC spectra of compound 1 revealed 13 carbon signals, including a ketone carbon (δ C 201.2), two olefinic carbons (δ C 166.3 and 127.8), an oxygenated methine carbon (δ C 74.5), an oxygenated quaternary carbon (δ C 78.1), and a methoxy carbon (δ C 48.6). All the above data indicated that compound 1 was a noreudesmanetype sesquiterpenoid. 10 The planar structure of compound 1 was further determined by 2D NMR experiments such as COSY, HMQC, and HMBC spectra (Figure 2) . The 
H-

1
H COSY spectrum revealed the two spin systems corresponding to H-1/H-2/H-3 and H-8/H-9. In the HMBC spectrum, the correlations from CH 3 -15 (δ H 1.37) to C-3 (δ C 74.5), C-4 (δ C 78.1), and C-5 (δ C 166.3), and from CH 3 -14 (δ H 1.41) to C-1 (δ C 33.9), C-10 (δ C 35.1), C-9 (δ C 39.6), and C-5 (δ C 166.3), clearly indicated that two methyl groups were located at C-4 and C-10, respectively. Further HMBC correlation from OCH 3 -4 (δ H 3.06) to C-4 (δ C 78.1) revealed the location of a methoxy group at C-4.
The relative stereochemistry of compound 1 was determined from the coupling constant as well as from a NOESY (Figure 2 ). The small coupling constant of the oxygenated proton at C-3 (J = 3.0 and 3.0 Hz) and the observed NOE correlations between H-3β/H-2β and CH 3 -15/H-6 confirmed the α-orientation of CH 3 -15 and OH-3, and β-orientation of OCH 3 -4, respectively. Further NOE correlations between CH 3 -14/H-2β, CH 3 -14/H-8β, and CH 3 -14/OCH 3 -4 clearly indicated the β-configuration of CH 3 -14 and OCH 3 -4, respectively. Therefore, compound 1 was identified as 4β-methoxy-11,12,13-trinor-5-eudesmene-7-one, and was named 4-methoxy-oxyphyllenone A. The previously known fifteen compounds were identified as yakuchinone A (2), 14 tectochrysin (3), 15 teuhetenone A (4), 16 (4S*,5E,10R*)-7-oxo-tri-nor-eudesm-5-en-4β-ol (5), 17 oxyphyllenodiol B (6),
16 teucrenone (9) (IC 50 value of 18.5 μM) . However, the other compounds showed no inhibitory activity in this assay (IC 50 values > 100 μM). Cell viability assay indicated that none of the compounds exhibited significant cytotoxicity at their effective concentration for the inhibition of NO production (data not shown). It has been reported that several diaryheptanoid and sesquiterpenoid from the fruits of A. oxyphylla were found to have inhibitory activity on NO production. [10] [11] [12] [13] 22 Taken together, our results suggested that A. oxyphylla may be a possible candidate for the treatment of inflammatory disease.
Experimental
General Procedures. IR spectra were recorded on a JASCO FT-IR 4100 spectrophotometer (Jasco, Japan). Optical rotations were measured using a JASCO DIP-1000 polarimeter (Jasco, Japan). The NMR spectra were recorded on Bruker ADVANCE III 400 MHz and ADVANCE 500 MHz (Bruker, Germany) spectrometers. The HR-ESI-MS spectra were performed on maXis 4G mass spectrometer (Bruker, Germany). Preparative HPLC was performed using a Waters 515 HPLC Pump with a Waters 2996 Photodiodearray detector and YMC J'sphere ODS-H80 column (4 μm, 150 × 20 mm, USA). Column chromatography was performed using a silica gel (70-230 mesh, Merck) and Lichroprep RP-18 (40-63 µm, Merck). TLC was performed using aluminum plates precoated with Kieselgel 60 F254 (Merck).
Plant Materials. The dried fruits of A. oxyphylla were purchased from Kyungdong herbal market, Seoul, Korea, in March 2011. The plant material was identified by Kyong Soon Lee, Emeritus Professor, Chungbuk National University. A voucher specimen (CBNU-11AO) was deposited at the Herbarium of the College of Pharmacy, Chungbuk National University, Korea.
Extraction and Isolation. Dried fruits of A. oxyphylla (3 Kg) were extracted with three times MeOH at room temperature. After filtration and evaporation of the solvent under reduced pressure, the combined methanol extract (470 g) was suspended in water (1.5 L), and partitioned with nhexane, CH 2 Cl 2 and EtOAc to afford extracts of n-hexane (66.3 g), CH 2 Cl 2 (156.1 g), EtOAc (24.6 g) and water layer, respectively. The CH 2 Cl 2 -soluble extract (156.1 g) was subjected to a silica gel column chromatography with a solvent system (n-hexane:CH 2 Cl 2 = 2:1 to CH 2 Cl 2 :MeOH = 1:1) to give six fractions (AOC1 -AOC6). Fraction 1 (35.5 g) was separated over a silica gel column with a solvent system (n-hexane:CH 2 Cl 2 = 5:1 to CH 2 Cl 2 :MeOH = 1:1) to give Measurement of NO Production and Cell Viability Assay. The nitrite concentration in the medium was determined as an indicator of NO production according to the Griess method previously described. 23 Briefly, RAW 264.7 cells were seeded into 96-well tissue culture plates at a density of 2 × 10 5 cells/mL, and stimulated with 1 μg/mL of LPS in the presence or absence of compounds. After incubation at 37 o C and 5% CO 2 atmosphere for 24 h, 100 μL of cell-free supernatant was mixed with 100 μL of Griess reagent containing equal volumes 0.2% (w/v) sulfanilamide in 5% (w/v) phosphoric acid and 0.2% (w/v) of N-(1-naphthyl)ethylenediamine solution to determine nitrite production. The absorbance was measured at 540 nm by a microplate reader. The remaining cells after Griess assay were used for viability with the CCK (Dojindo, Tokyo, Japan)-based colorimetric assay.
